NO20034560L - Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer - Google Patents

Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer

Info

Publication number
NO20034560L
NO20034560L NO20034560A NO20034560A NO20034560L NO 20034560 L NO20034560 L NO 20034560L NO 20034560 A NO20034560 A NO 20034560A NO 20034560 A NO20034560 A NO 20034560A NO 20034560 L NO20034560 L NO 20034560L
Authority
NO
Norway
Prior art keywords
remedy
inflammatory diseases
topical ophthalmic
ocular inflammatory
ophthalmic treatment
Prior art date
Application number
NO20034560A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034560D0 (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20034560D0 publication Critical patent/NO20034560D0/no
Publication of NO20034560L publication Critical patent/NO20034560L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO20034560A 2001-04-12 2003-10-10 Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer NO20034560L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28316901P 2001-04-12 2001-04-12
PCT/JP2002/003664 WO2002085359A1 (en) 2001-04-12 2002-04-12 Agent for topical ophthalmic treatment of ocular inflammatory diseases

Publications (2)

Publication Number Publication Date
NO20034560D0 NO20034560D0 (no) 2003-10-10
NO20034560L true NO20034560L (no) 2003-12-09

Family

ID=23084835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034560A NO20034560L (no) 2001-04-12 2003-10-10 Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer

Country Status (12)

Country Link
US (1) US20020187998A1 (US20020187998A1-20021212-C00005.png)
EP (1) EP1379247A1 (US20020187998A1-20021212-C00005.png)
JP (1) JP2004529928A (US20020187998A1-20021212-C00005.png)
KR (1) KR20040007494A (US20020187998A1-20021212-C00005.png)
CN (1) CN1503671A (US20020187998A1-20021212-C00005.png)
AR (1) AR033151A1 (US20020187998A1-20021212-C00005.png)
BR (1) BR0208939A (US20020187998A1-20021212-C00005.png)
CA (1) CA2445508A1 (US20020187998A1-20021212-C00005.png)
MX (1) MXPA03009273A (US20020187998A1-20021212-C00005.png)
NO (1) NO20034560L (US20020187998A1-20021212-C00005.png)
NZ (1) NZ529255A (US20020187998A1-20021212-C00005.png)
WO (1) WO2002085359A1 (US20020187998A1-20021212-C00005.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ530845A (en) * 2001-07-06 2006-03-31 Sucampo Ag Composition for topical administration
US20050043286A1 (en) * 2001-11-19 2005-02-24 Mario Fsadni Use of an ascomycin for the treatment of blepharitis
EP1536793A1 (en) * 2002-08-09 2005-06-08 Sucampo Pharmaceuticals, Inc. Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US20040198763A1 (en) * 2003-01-16 2004-10-07 Sucampo Ag Method of treating dry eye with a macrolide compound
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
BRPI0608152A2 (pt) 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
CA2645488C (en) * 2006-03-23 2014-09-02 Macusight, Inc. Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
US8536190B2 (en) * 2007-01-30 2013-09-17 Allergan, Inc. Treating unwanted ocular conditions using an ascomycin macrolactam
US20170198026A1 (en) * 2014-06-06 2017-07-13 The Schepens Eye Research Institute, Inc. Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases
EP3721868B1 (en) * 2015-01-26 2022-06-01 Bausch & Lomb Incorporated Ophthalmic suspension composition
KR101710412B1 (ko) 2015-09-15 2017-02-27 인제대학교 산학협력단 Ycg063을 유효성분으로 함유하는 염증성 안구질환 예방 또는 치료용 약학조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
DK0406791T3 (da) * 1989-07-05 1995-03-27 Fujisawa Pharmaceutical Co Vandigt flydende præparat til ekstern anvendelse
DE69021833T2 (de) * 1989-11-09 1996-03-21 Sandoz Ag Heteroatome enthaltende tricyclische Verbindungen.
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
US5514686A (en) * 1991-04-26 1996-05-07 Fujisawa Pharmaceutical Co., Ltd. Use of macrolide compounds for eye diseases
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen

Also Published As

Publication number Publication date
CA2445508A1 (en) 2002-10-31
BR0208939A (pt) 2004-04-20
NZ529255A (en) 2006-09-29
EP1379247A1 (en) 2004-01-14
AR033151A1 (es) 2003-12-03
MXPA03009273A (es) 2004-02-12
WO2002085359A1 (en) 2002-10-31
US20020187998A1 (en) 2002-12-12
KR20040007494A (ko) 2004-01-24
CN1503671A (zh) 2004-06-09
JP2004529928A (ja) 2004-09-30
NO20034560D0 (no) 2003-10-10

Similar Documents

Publication Publication Date Title
NO20034560D0 (no) Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
ATE439844T1 (de) Kombinationen für die behandlung entzündlicher erkrankungen
ATE441417T1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
ATE374196T1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20044450L (no) Kombinasjon av brimonidine og timolol for topisk oftalmisk anvendelse
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DE60226702D1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
NO20044402L (no) Kombinasjonsbehandling av kemokine-medierte sykdommer
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
ECSP055844A (es) Nuevos compuestos triciclicos
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60120961D1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
ATE272619T1 (de) Anilin-disulfid-derivate zur behandlung allergischer erkrankungen
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application